Respiratory Immunopharmacology
71 – 80 of 92
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Primary lysis of eosinophils as a major mode of activation of eosinophils in human diseased tissues.
(
- Contribution to journal › Letter
-
Mark
Simvastatin-induced effects on bronchial epithelial cells from COPD donors.
(
- Contribution to journal › Letter
-
Mark
Interferon regulatory factor 3 activation mediates viral stimulus-induced bronchial production of thymic stromal lymphopoietin.
(
- Contribution to journal › Letter
- 2012
-
Mark
Capacity of capsazepinoids to relax human small airways and inhibit TLR3-induced TSLP and IFNβ production in diseased bronchial epithelial cells.
(
- Contribution to journal › Article
-
Mark
Resolution of leucocyte-mediated mucosal diseases. A novel in vivo paradigm for drug development
(
- Contribution to journal › Scientific review
-
Mark
Increased lung neutrophil apoptosis and inflammation resolution
(
- Contribution to journal › Letter
-
Mark
Viral Stimuli Trigger Exaggerated Thymic Stromal Lymphopoietin Expression by Chronic Obstructive Pulmonary Disease Epithelium: Role of Endosomal TLR3 and Cytosolic RIG-I-Like Helicases.
(
- Contribution to journal › Article
- 2011
-
Mark
Effects of the cyclin-dependent kinase inhibitor R-roscovitine on eosinophil survival and clearance.
(
- Contribution to journal › Article
-
Mark
Increased fecal leukocytes may reflect resolution of IBD.
(
- Contribution to journal › Article
-
Mark
dsRNA-induced expression of thymic stromal lymphopoietin (TSLP) in asthmatic epithelial cells is inhibited by a small airway relaxant.
(
- Contribution to journal › Article